AngioDynamics to Hold Fiscal 2006 Third Quarter Financial Results Conference Call on Tuesday, March 21, 2006.

QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release fiscal 2006 third quarter results after the market closes on Tuesday, March 21, 2006.

Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on March 21 to discuss these results and to answer questions.

To participate in the live call by telephone, please dial 800-561-2718 from the U.S., or for international callers, please dial 617-614-3525. Please enter the passcode 60630716.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' web site at http://investor.angiodynamics.com. To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install the necessary audio software.

A replay will be available on the web site. A telephone replay will be available from 6:30 p.m. Eastern Time on March 21, 2006, through 11:59 p.m. Eastern Time on March 28, 2006, by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering conference ID number 83919989.

About AngioDynamics

AngioDynamics, Inc. (www.angiodynamics.com) is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics, Inc. designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The Company's diverse product line includes angiographic catheters, hemodialysis catheters, endovascular laser venous system products, PTA dilation balloon catheters, image-guided vascular access products, thrombolytic products and drainage products.